-
1
-
-
85042013874
-
-
US Cancer StatisticsWorking Group, Accessed June 28, 2017, Centers for Disease Control and Prevention website
-
US Cancer StatisticsWorking Group. United States Cancer Statistics (USCS): 1999-2014 cancer incidence and mortality data. Centers for Disease Control and Prevention website. https://www.cdc .gov/cancer/npcr/uscs/index.htm. 2017. Accessed June 28, 2017.
-
(2017)
United States Cancer Statistics (USCS): 1999-2014 Cancer Incidence and Mortality Data
-
-
-
2
-
-
79952945610
-
-
SEER (Surveillance, Epidemiology, and End Results Program), Accessed November 2, 2016.
-
SEER (Surveillance, Epidemiology, and End Results Program). SEER Stat Fact Sheets: Ovarian cancer. https://seer.cancer.gov/statfacts/html/ovary .html. Accessed November 2, 2016.
-
SEER Stat Fact Sheets: Ovarian Cancer
-
-
-
3
-
-
85015908413
-
Screening for gynecologic conditions with pelvic examination: US Preventive Services Task Force recommendation statement
-
US Preventive Services Task Force
-
Bibbins-Domingo K, Grossman DC, Curry SJ, et al; US Preventive Services Task Force. Screening for gynecologic conditions with pelvic examination: US Preventive Services Task Force recommendation statement. JAMA. 2017;317(9): 947-953.
-
(2017)
JAMA.
, vol.317
, Issue.9
, pp. 947-953
-
-
Bibbins-Domingo, K.1
Grossman, D.C.2
Curry, S.J.3
-
4
-
-
84867136524
-
Screening for ovarian cancer: U.S. Preventive Services Task Force reaffirmation recommendation statement
-
U.S. Preventive Services Task Force
-
Moyer VA; U.S. Preventive Services Task Force. Screening for ovarian cancer: U.S. Preventive Services Task Force reaffirmation recommendation statement. Ann Intern Med. 2012;157(12):900-904.
-
(2012)
Ann Intern Med.
, vol.157
, Issue.12
, pp. 900-904
-
-
Moyer, V.A.1
-
6
-
-
77649246296
-
-
US Preventive Services Task Force, Rockville, MD: US Preventive Services Task Force
-
US Preventive Services Task Force. U.S. Preventive Services Task Force Procedure Manual. Rockville, MD: US Preventive Services Task Force; 2015.
-
(2015)
U.S. Preventive Services Task Force Procedure Manual
-
-
-
10
-
-
84882451638
-
Risks and benefits of screening asymptomatic women for ovarian cancer: A systematic review and meta-analysis
-
Reade CJ, Riva JJ, Busse JW, Goldsmith CH, Elit L. Risks and benefits of screening asymptomatic women for ovarian cancer: A systematic review and meta-analysis. Gynecol Oncol. 2013;130(3):674-681.
-
(2013)
Gynecol Oncol.
, vol.130
, Issue.3
, pp. 674-681
-
-
Reade, C.J.1
Riva, J.J.2
Busse, J.W.3
Ch, G.4
Elit, L.5
-
11
-
-
85034109734
-
Outcomes from ovarian cancer screening in the PLCO trial: Histologic heterogeneity impacts detection, overdiagnosis and survival
-
Temkin SM, Miller EA, Samimi G, Berg CD, Pinsky P, Minasian L. Outcomes from ovarian cancer screening in the PLCO trial: Histologic heterogeneity impacts detection, overdiagnosis and survival. Eur J Cancer. 2017;87:182-188.
-
(2017)
Eur J Cancer.
, vol.87
, pp. 182-188
-
-
Temkin, S.M.1
Miller, E.A.2
Samimi, G.3
Berg, C.D.4
Pinsky, P.5
Minasian, L.6
-
12
-
-
0035318124
-
Current methods of the US Preventive Services Task Force: A review of the process
-
Methods Work Group, Third US Preventive Services Task Force
-
Harris RP, Helfand M, Woolf SH, et al; Methods Work Group, Third US Preventive Services Task Force. Current methods of the US Preventive Services Task Force: A review of the process. Am J Prev Med. 2001;20(3)(suppl):21-35.
-
(2001)
Am J Prev Med.
, vol.20
, Issue.3
, pp. 21-35
-
-
Harris, R.P.1
Helfand, M.2
Woolf, S.H.3
-
13
-
-
84959862763
-
Tumors of the peritoneum: Epithelial tumors of Müllerian type
-
In: Kurman RJ, Carcangiu ML, Herrington CS, Young RH, eds., Lyon, France: International Agency for Research on Cancer
-
Daya D, Cheung A, Khunamornpong S, et al. Tumors of the peritoneum: Epithelial tumors of Müllerian type. In: Kurman RJ, Carcangiu ML, Herrington CS, Young RH, eds. WHO Classification of Tumors of Female Reproductive Organs. 4th ed. Lyon, France: International Agency for Research on Cancer; 2014:92-93.
-
(2014)
WHO Classification of Tumors of Female Reproductive Organs. 4th Ed.
, pp. 92-93
-
-
Daya, D.1
Cheung, A.2
Khunamornpong, S.3
-
14
-
-
84891161285
-
Staging classification for cancer of the ovary, fallopian tube, and peritoneum
-
FIGO Committee on Gynecologic Oncology
-
Prat J; FIGO Committee on Gynecologic Oncology. Staging classification for cancer of the ovary, fallopian tube, and peritoneum. Int J Gynaecol Obstet. 2014;124(1):1-5.
-
(2014)
Int J Gynaecol Obstet.
, vol.124
, Issue.1
, pp. 1-5
-
-
Prat, J.1
-
15
-
-
80052135846
-
Morphological subtypes of ovarian carcinoma: A review with emphasis on new developments and pathogenesis
-
McCluggageWG. Morphological subtypes of ovarian carcinoma: A review with emphasis on new developments and pathogenesis. Pathology. 2011; 43(5):420-432.
-
(2011)
Pathology.
, vol.43
, Issue.5
, pp. 420-432
-
-
McCluggage, W.G.1
-
16
-
-
84962496502
-
The dualistic model of ovarian carcinogenesis: Revisited, revised, and expanded
-
Kurman RJ, Shih IeM. The dualistic model of ovarian carcinogenesis: Revisited, revised, and expanded. Am J Pathol. 2016;186(4):733-747.
-
(2016)
Am J Pathol.
, vol.186
, Issue.4
, pp. 733-747
-
-
Kurman, R.J.1
Shihie, M.2
-
17
-
-
84899145661
-
The fallopian tube as the origin of high grade serous ovarian cancer: Review of a paradigm shift
-
Reade CJ, McVey RM, Tone AA, et al. The fallopian tube as the origin of high grade serous ovarian cancer: Review of a paradigm shift. J Obstet Gynaecol Can. 2014;36(2):133-140.
-
(2014)
J Obstet Gynaecol Can.
, vol.36
, Issue.2
, pp. 133-140
-
-
Reade, C.J.1
McVey, R.M.2
Tone, A.A.3
-
18
-
-
77953395873
-
CONSORT 2010 statement: Updated guidelines for reporting parallel group randomized trials
-
CONSORT Group
-
Schulz KF, Altman DG, Moher D; CONSORT Group. CONSORT 2010 statement: Updated guidelines for reporting parallel group randomized trials. Ann Intern Med. 2010;152(11):726-732.
-
(2010)
Ann Intern Med.
, vol.152
, Issue.11
, pp. 726-732
-
-
Schulz, K.F.1
Altman, D.G.2
Moher, D.3
-
20
-
-
27544448084
-
Ovarian cancer screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial: Findings from the initial screen of a randomized trial
-
PLCO Project Team
-
Buys SS, Partridge E, Greene MH, et al; PLCO Project Team. Ovarian cancer screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial: Findings from the initial screen of a randomized trial. Am J Obstet Gynecol. 2005;193(5):1630-1639.
-
(2005)
Am J Obstet Gynecol.
, vol.193
, Issue.5
, pp. 1630-1639
-
-
Buys, S.S.1
Partridge, E.2
Greene, M.H.3
-
21
-
-
79958036419
-
Effect of screening on ovarian cancer mortality: The Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening randomized controlled trial
-
PLCO Project Team
-
Buys SS, Partridge E, Black A, et al; PLCO Project Team. Effect of screening on ovarian cancer mortality: The Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening randomized controlled trial. JAMA. 2011;305(22):2295-2303.
-
(2011)
JAMA.
, vol.305
, Issue.22
, pp. 2295-2303
-
-
Buys, S.S.1
Partridge, E.2
Black, A.3
-
22
-
-
63149087256
-
Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: Results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)
-
Menon U, Gentry-Maharaj A, Hallett R, et al. Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: Results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS). Lancet Oncol. 2009;10(4):327-340.
-
(2009)
Lancet Oncol.
, vol.10
, Issue.4
, pp. 327-340
-
-
Menon, U.1
Gentry-Maharaj, A.2
Hallett, R.3
-
23
-
-
84957680337
-
Quality assurance and its impact on ovarian visualization rates in the multicenter United Kingdom Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)
-
Sharma A, Burnell M, Gentry-Maharaj A, et al. Quality assurance and its impact on ovarian visualization rates in the multicenter United Kingdom Collaborative Trial of Ovarian Cancer Screening (UKCTOCS). Ultrasound Obstet Gynecol. 2016;47(2):228-235.
-
(2016)
Ultrasound Obstet Gynecol.
, vol.47
, Issue.2
, pp. 228-235
-
-
Sharma, A.1
Burnell, M.2
Gentry-Maharaj, A.3
-
24
-
-
84943139487
-
Psychosocial factors associated with withdrawal from the United Kingdom Collaborative Trial of Ovarian Cancer Screening after 1 episode of repeat screening
-
Jenkins V, Fallowfield L, Langridge C, et al. Psychosocial factors associated with withdrawal from the United Kingdom Collaborative Trial of Ovarian Cancer Screening after 1 episode of repeat screening. Int J Gynecol Cancer. 2015;25(8):1519-1525.
-
(2015)
Int J Gynecol Cancer.
, vol.25
, Issue.8
, pp. 1519-1525
-
-
Jenkins, V.1
Fallowfield, L.2
Langridge, C.3
-
25
-
-
84904808256
-
Psychological morbidity associated with ovarian cancer screening: Results from more than 23, 000 women in the randomised trial of ovarian cancer screening (UKCTOCS)
-
UKCTOCS Trialists
-
Barrett J, Jenkins V, Farewell V, et al; UKCTOCS Trialists. Psychological morbidity associated with ovarian cancer screening: Results from more than 23, 000 women in the randomised trial of ovarian cancer screening (UKCTOCS). BJOG. 2014;121(9): 1071-1079.
-
(2014)
BJOG.
, vol.121
, Issue.9
, pp. 1071-1079
-
-
Barrett, J.1
Jenkins, V.2
Farewell, V.3
-
26
-
-
84874039085
-
Potential effect of the risk of ovarian cancer algorithm (ROCA) on the mortality outcome of the Prostate, Lung, Colorectal and Ovarian (PLCO) trial
-
Pinsky PF, Zhu C, Skates SJ, et al. Potential effect of the risk of ovarian cancer algorithm (ROCA) on the mortality outcome of the Prostate, Lung, Colorectal and Ovarian (PLCO) trial. Int J Cancer. 2013;132(9):2127-2133.
-
(2013)
Int J Cancer.
, vol.132
, Issue.9
, pp. 2127-2133
-
-
Pinsky, P.F.1
Zhu, C.2
Skates, S.J.3
-
27
-
-
67249153691
-
Cumulative incidence of false-positive results in repeated, multimodal cancer screening
-
Croswell JM, Kramer BS, Kreimer AR, et al. Cumulative incidence of false-positive results in repeated, multimodal cancer screening. Ann Fam Med. 2009;7(3):212-222.
-
(2009)
Ann Fam Med.
, vol.7
, Issue.3
, pp. 212-222
-
-
Croswell, J.M.1
Kramer, B.S.2
Kreimer, A.R.3
-
28
-
-
65649129680
-
Results from four rounds of ovarian cancer screening in a randomized trial
-
PLCO Project Team
-
Partridge E, Kreimer AR, Greenlee RT, et al; PLCO Project Team. Results from four rounds of ovarian cancer screening in a randomized trial. Obstet Gynecol. 2009;113(4):775-782.
-
(2009)
Obstet Gynecol.
, vol.113
, Issue.4
, pp. 775-782
-
-
Partridge, E.1
Kreimer, A.R.2
Greenlee, R.T.3
-
29
-
-
34648831557
-
Changes in cancer worry associated with participation in ovarian cancer screening
-
Andersen MR, Drescher CW, Zheng Y, et al. Changes in cancer worry associated with participation in ovarian cancer screening. Psychooncology. 2007;16(9):814-820.
-
(2007)
Psychooncology.
, vol.16
, Issue.9
, pp. 814-820
-
-
Andersen, M.R.1
Drescher, C.W.2
Zheng, Y.3
-
30
-
-
2942608986
-
Compliance of average- and intermediate-risk women to semiannual ovarian cancer screening
-
Drescher CW, Nelson J, Peacock S, Andersen MR, McIntoshMW, Urban N. Compliance of average- and intermediate-risk women to semiannual ovarian cancer screening. Cancer Epidemiol Biomarkers Prev. 2004;13(4):600-606.
-
(2004)
Cancer Epidemiol Biomarkers Prev.
, vol.13
, Issue.4
, pp. 600-606
-
-
Drescher, C.W.1
Nelson, J.2
Peacock, S.3
Andersen, M.R.4
McIntosh, M.W.5
Urban, N.6
-
31
-
-
84959863810
-
Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): A randomised controlled trial
-
10022
-
Jacobs IJ, Menon U, Ryan A, et al. Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): A randomised controlled trial. Lancet. 2016;387(10022):945-956.
-
(2016)
Lancet.
, vol.387
, pp. 945-956
-
-
Jacobs, I.J.1
Menon, U.2
Ryan, A.3
-
32
-
-
0027405117
-
Prevalence screening for ovarian cancer in postmenopausal women by CA-125 measurement and ultrasonography
-
Jacobs I, Davies AP, Bridges J, et al. Prevalence screening for ovarian cancer in postmenopausal women by CA-125 measurement and ultrasonography. BMJ. 1993;306(6884):1030-1034.
-
(1993)
BMJ.
, vol.306
, Issue.6884
, pp. 1030-1034
-
-
Jacobs, I.1
Davies, A.P.2
Bridges, J.3
-
33
-
-
0033541548
-
Screening for ovarian cancer: A pilot randomised controlled trial
-
Jacobs IJ, Skates SJ, MacDonald N, et al. Screening for ovarian cancer: A pilot randomised controlled trial. Lancet. 1999;353(9160):1207-1210.
-
(1999)
Lancet.
, vol.353
, Issue.9160
, pp. 1207-1210
-
-
Jacobs, I.J.1
Skates, S.J.2
MacDonald, N.3
-
34
-
-
84930654984
-
Risk algorithm using serial biomarker measurements doubles the number of screen-detected cancers compared with a single-threshold rule in the United Kingdom Collaborative Trial of Ovarian Cancer Screening
-
Menon U, Ryan A, Kalsi J, et al. Risk algorithm using serial biomarker measurements doubles the number of screen-detected cancers compared with a single-threshold rule in the United Kingdom Collaborative Trial of Ovarian Cancer Screening. J Clin Oncol. 2015;33(18):2062-2071.
-
(2015)
J Clin Oncol.
, vol.33
, Issue.18
, pp. 2062-2071
-
-
Menon, U.1
Ryan, A.2
Kalsi, J.3
-
35
-
-
84995426666
-
Extended mortality results for ovarian cancer screening in the PLCO trial with median 15 years follow-up
-
Pinsky PF, Yu K, Kramer BS, et al. Extended mortality results for ovarian cancer screening in the PLCO trial with median 15 years follow-up. Gynecol Oncol. 2016;143(2):270-275.
-
(2016)
Gynecol Oncol.
, vol.143
, Issue.2
, pp. 270-275
-
-
Pinsky, P.F.1
Yu, K.2
Kramer, B.S.3
-
36
-
-
84967318147
-
Ovarian cancer screening in menopausal females with a family history of breast or ovarian cancer
-
Lai T, Kessel B, Ahn HJ, Terada KY. Ovarian cancer screening in menopausal females with a family history of breast or ovarian cancer. J Gynecol Oncol. 2016;27(4):e41.
-
(2016)
J Gynecol Oncol.
, vol.27
, Issue.4
, pp. e41
-
-
Lai, T.1
Kessel, B.2
Ahn, H.J.3
Terada, K.Y.4
-
37
-
-
84866521243
-
Impact of screening test performance and cost on mortality reduction and cost-effectiveness of multimodal ovarian cancer screening
-
Drescher CW, Hawley S, Thorpe JD, et al. Impact of screening test performance and cost on mortality reduction and cost-effectiveness of multimodal ovarian cancer screening. Cancer Prev Res (Phila). 2012;5(8):1015-1024.
-
(2012)
Cancer Prev Res (Phila).
, vol.5
, Issue.8
, pp. 1015-1024
-
-
Drescher, C.W.1
Hawley, S.2
Thorpe, J.D.3
-
38
-
-
62149132122
-
Recruitment methods employed in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
-
Gren L, Broski K, Childs J, et al. Recruitment methods employed in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Clin Trials. 2009;6(1):52-59.
-
(2009)
Clin Trials.
, vol.6
, Issue.1
, pp. 52-59
-
-
Gren, L.1
Broski, K.2
Childs, J.3
-
39
-
-
0344270007
-
Calculation of the risk of ovarian cancer from serial CA-125 values for preclinical detection in postmenopausal women
-
Skates SJ, Menon U, MacDonald N, et al. Calculation of the risk of ovarian cancer from serial CA-125 values for preclinical detection in postmenopausal women. J Clin Oncol. 2003;21(10) (suppl):206s-210s.
-
(2003)
J Clin Oncol.
, vol.21
, Issue.10
, pp. 206s-210s
-
-
Skates, S.J.1
Menon, U.2
MacDonald, N.3
-
40
-
-
1542678929
-
Screening based on the risk of cancer calculation from Bayesian hierarchical changepoint and mixture models of longitudinal markers
-
Skates SJ, Pauler DK, Jacobs IJ. Screening based on the risk of cancer calculation from Bayesian hierarchical changepoint and mixture models of longitudinal markers. J AmStat Assoc. 2001;26:429-439.
-
(2001)
J AmStat Assoc.
, vol.26
, pp. 429-439
-
-
Skates, S.J.1
Pauler, D.K.2
Jacobs, I.J.3
-
41
-
-
85042012153
-
The bimanual ovarian palpation examination in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial: Performance and complications
-
Doroudi M, Kramer BS, Pinsky PF. The bimanual ovarian palpation examination in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial: Performance and complications. J Med Screen. 2017;24(4):220-222.
-
(2017)
J Med Screen.
, vol.24
, Issue.4
, pp. 220-222
-
-
Doroudi, M.1
Kramer, B.S.2
Pinsky, P.F.3
-
42
-
-
84894265334
-
Reporting of primary analyses and multiplicity adjustment in recent analgesic clinical trials: ACTTION systematic review and recommendations
-
Gewandter JS, Smith SM, McKeown A, et al. Reporting of primary analyses and multiplicity adjustment in recent analgesic clinical trials: ACTTION systematic review and recommendations. Pain. 2014;155(3):461-466.
-
(2014)
Pain.
, vol.155
, Issue.3
, pp. 461-466
-
-
Gewandter, J.S.1
Smith, S.M.2
McKeown, A.3
-
43
-
-
77950273246
-
CONSORT 2010 explanation and elaboration: Updated guidelines for reporting parallel group randomised trials
-
Moher D, Hopewell S, Schulz KF, et al. CONSORT 2010 explanation and elaboration: Updated guidelines for reporting parallel group randomised trials. BMJ. 2010;340:c869.
-
(2010)
BMJ.
, vol.340
, pp. c869
-
-
Moher, D.1
Hopewell, S.2
Schulz, K.F.3
-
44
-
-
79958043675
-
-
National Cancer Institute website, Accessed November 6, 2016.
-
Howlader N, Noone AM, Krapcho M, et al. SEER Cancer Statistics Review, 1975-2013. National Cancer Institute website. https://seer.cancer.gov /csr/1975-2013/. Accessed November 6, 2016.
-
SEER Cancer Statistics Review, 1975-2013
-
-
Howlader, N.1
Noone, A.M.2
Krapcho, M.3
-
45
-
-
84901292378
-
Recent concepts of ovarian carcinogenesis: Type i and type II
-
Koshiyama M, Matsumura N, Konishi I. Recent concepts of ovarian carcinogenesis: Type I and type II. Biomed Res Int. 2014;2014:934261.
-
(2014)
Biomed Res Int.
, vol.2014
, pp. 934261
-
-
Koshiyama, M.1
Matsumura, N.2
Konishi, I.3
-
46
-
-
79959328816
-
Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer-shifting the paradigm
-
Kurman RJ, Shih IeM. Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer-shifting the paradigm. Hum Pathol. 2011;42 (7):918-931.
-
(2011)
Hum Pathol.
, vol.42
, Issue.7
, pp. 918-931
-
-
Kurman, R.J.1
Shihie, M.2
-
47
-
-
85042030544
-
-
Institute of Medicine, Committee on the State of the Science in Ovarian Cancer Research, Board on Health Care Services, National Academies of Sciences, Engineering, and Medicine, Washington, DC: National Academies Press; 2016.
-
Institute of Medicine, Committee on the State of the Science in Ovarian Cancer Research, Board on Health Care Services, National Academies of Sciences, Engineering, and Medicine. Ovarian Cancers: Evolving Paradigms in Research and Care. Washington, DC: National Academies Press; 2016.
-
Ovarian Cancers: Evolving Paradigms in Research and Care
-
-
-
48
-
-
84908173579
-
Ovarian cancer
-
Jayson GC, Kohn EC, Kitchener HC, Ledermann JA. Ovarian cancer. Lancet. 2014;384(9951):1376-1388.
-
(2014)
Lancet.
, vol.384
, Issue.9951
, pp. 1376-1388
-
-
Jayson, G.C.1
Kohn, E.C.2
Kitchener, H.C.3
Ledermann, J.A.4
-
49
-
-
84981276294
-
Salpingo-oophorectomy at the time of benign hysterectomy: A systematic review
-
Society of Gynecologic Surgeons Systematic Review Group
-
Evans EC, Matteson KA, Orejuela FJ, et al; Society of Gynecologic Surgeons Systematic Review Group. Salpingo-oophorectomy at the time of benign hysterectomy: A systematic review. Obstet Gynecol. 2016;128(3):476-485.
-
(2016)
Obstet Gynecol.
, vol.128
, Issue.3
, pp. 476-485
-
-
Evans, E.C.1
Matteson, K.A.2
Orejuela, F.J.3
-
50
-
-
77952878109
-
Prophylactic bilateral oophorectomy or removal of remaining ovary at the time of hysterectomy in the United States, 1979-2004
-
Lowder JL, Oliphant SS, Ghetti C, Burrows LJ, Meyn LA, Balk J. Prophylactic bilateral oophorectomy or removal of remaining ovary at the time of hysterectomy in the United States, 1979-2004. Am J Obstet Gynecol. 2010;202(6): 538.e1-538.e9.
-
(2010)
Am J Obstet Gynecol.
, vol.202
, Issue.6
, pp. 538e1-538e9
-
-
Lowder, J.L.1
Oliphant, S.S.2
Ghetti, C.3
Burrows, L.J.4
Meyn, L.A.5
Balk, J.6
-
51
-
-
84903378966
-
Tubal ligation, hysterectomy, unilateral oophorectomy, and risk of ovarian cancer in the Nurses' Health Studies
-
Rice MS, Hankinson SE, Tworoger SS. Tubal ligation, hysterectomy, unilateral oophorectomy, and risk of ovarian cancer in the Nurses' Health Studies. Fertil Steril. 2014;102(1):192-198.
-
(2014)
Fertil Steril.
, vol.102
, Issue.1
, pp. 192-198
-
-
Rice, M.S.1
Hankinson, S.E.2
Tworoger, S.S.3
-
52
-
-
85009758047
-
Novel risk models for early detection and screening of ovarian cancer
-
Russell MR, D'Amato A, Graham C, et al. Novel risk models for early detection and screening of ovarian cancer. Oncotarget. 2017;8(1):785-797.
-
(2017)
Oncotarget.
, vol.8
, Issue.1
, pp. 785-797
-
-
Russell, M.R.1
D'Amato, A.2
Graham, C.3
-
53
-
-
43449104703
-
A randomized study of screening for ovarian cancer: A multicenter study in Japan
-
Kobayashi H, Yamada Y, Sado T, et al. A randomized study of screening for ovarian cancer: A multicenter study in Japan. Int J Gynecol Cancer. 2008;18(3):414-420.
-
(2008)
Int J Gynecol Cancer.
, vol.18
, Issue.3
, pp. 414-420
-
-
Kobayashi, H.1
Yamada, Y.2
Sado, T.3
-
54
-
-
81855216360
-
Long-term survival of women with epithelial ovarian cancer detected by ultrasonographic screening
-
van Nagell JR Jr, Miller RW, DeSimone CP, et al. Long-term survival of women with epithelial ovarian cancer detected by ultrasonographic screening. Obstet Gynecol. 2011;118(6):1212-1221.
-
(2011)
Obstet Gynecol.
, vol.118
, Issue.6
, pp. 1212-1221
-
-
Van Nagell, J.R.1
Miller, R.W.2
De Simone, C.P.3
-
55
-
-
85042016906
-
Complications from surgeries prompted by ovarian cancer screening
-
Miller RW, Pavlik EJ, Baldwin LA, et al. Complications from surgeries prompted by ovarian cancer screening. Gynecol Oncol. 2015;137(suppl 1):180.
-
(2015)
Gynecol Oncol.
, vol.137
, pp. 180
-
-
Miller, R.W.1
Pavlik, E.J.2
Baldwin, L.A.3
|